Mixed Deck — All CNPR Topics Flashcards
100 cards from real CNPR practice questions. Tap to flip, then mark Knew It or Still Learning — missed cards come back until you master them.
Read the first 20 Mixed Deck — All CNPR Topics flashcards as text
A drug's 'therapeutic index' (TI) measures the relationship between:
Answer: The toxic dose and the effective dose — a narrow TI indicates a higher risk drug
The therapeutic index (TD50/ED50) compares the dose causing toxicity to the dose producing the desired effect; a narrow TI means little margin between effective and harmful doses.
In pharmacology, what does 'half-life' (t½) of a drug mean?
Answer: The time required for the plasma concentration of a drug to reduce by 50%
Half-life is the time required for the concentration of a drug in the bloodstream to decrease by half, which determines dosing intervals.
A new pharmaceutical rep receives a territory that has been vacant for six months. What should be their FIRST priority?
Answer: Conduct a territory audit by reviewing historical Rx data, CRM records, and physician profiles before any visits
A territory audit provides the context needed to develop a strategic plan and avoid repeating past mistakes before investing time in physician calls.
Which organization publishes the Physicians' Desk Reference (PDR), a widely used compendium of drug prescribing information?
Answer: PDR Network (formerly Medical Economics)
The PDR is published by PDR Network and compiles FDA-approved prescribing information (package inserts) from pharmaceutical manufacturers for use by healthcare professionals.
The requirement for pharmaceutical companies to submit 'Dear Healthcare Provider' (DHCP) letters is typically triggered by:
Answer: Important new safety information such as a label change or market withdrawal
FDA may require or companies may issue DHCP letters to rapidly communicate important safety updates, label changes, or recall information to prescribers.
Which FDA program provides expedited development and review for drugs intended to treat serious conditions where preliminary evidence shows the drug may demonstrate substantial improvement over available therapies?
Answer: Breakthrough Therapy designation
Breakthrough Therapy designation provides intensive FDA guidance and organizational commitment to expedite development of drugs showing early promise against serious conditions.
In managed care, rebates are typically paid by drug manufacturers to:
Answer: Pharmacy Benefit Managers or health plans in exchange for favorable formulary placement
Manufacturers negotiate rebates paid to PBMs or health plans in return for favorable formulary status (preferred tier placement), which increases patient and prescriber access to their drug.
Which approach best demonstrates mastery of fda regulations in CNPR practice?
Answer: Applying principles to novel situations with sound judgment
True mastery involves understanding underlying principles well enough to apply them to new and unfamiliar situations with professional judgment.
In CNPR practice, what is the best approach to quality improvement in product knowledge?
Answer: Use data-driven methods with measurable outcomes
Data-driven quality improvement with measurable outcomes ensures that changes actually produce the intended improvements and can be verified.
Which act mandates accurate labeling of pharmaceutical products?
Answer: Food, Drug, and Cosmetic Act
The Federal Food, Drug, and Cosmetic (FD&C) Act, passed in 1938, is the primary law governing the safety and labeling of food, drugs, cosmetics, and medical devices in the United States. It mandates that pharmaceutical products be accurately labeled with information regarding their ingredients, uses, warnings, and directions for safe use.
A physician mentions that their patients struggle to afford your branded medication. The most appropriate response is to:
Answer: Inform the physician about patient assistance programs and co-pay support options offered by your company
Patient assistance programs are a legitimate and important resource that reps should be prepared to discuss to remove access barriers.
Under Good Clinical Practice (GCP) guidelines, how long must trial records typically be retained after trial completion?
Answer: At least 2 years after the last marketing approval
ICH E6 GCP guidelines require essential documents to be retained for at least 2 years after the last marketing approval or after the investigational drug is discontinued.
What is the value of continuing education in market analysis for CNPR professionals?
Answer: It keeps professionals current with evolving standards and practices
Continuing education ensures professionals stay current with the latest developments, standards, and best practices in their field.
What is the primary goal of Phase III clinical trials?
Answer: To confirm efficacy and monitor adverse reactions in large patient populations
Phase III trials involve hundreds to thousands of patients and are designed to confirm effectiveness and gather safety data needed for NDA submission.
Which drug classification is used to describe medications that reduce fever?
Answer: Antipyretic
Antipyretics are drugs that reduce fever; the prefix 'anti-' means against and 'pyretic' relates to fire/fever.
A CNPR certified professional is asked to provide services outside their scope of competence. The CORRECT ethical response is to:
Answer: Decline and refer to a qualified professional
Ethical practice requires professionals to work within their scope of competence. Accepting work beyond one's qualifications can lead to substandard results and potential harm. Referring to qualified professionals ensures proper service delivery.
What is the primary difference between Medicare and Medicaid?
Answer: Medicare is age/disability-based federal insurance; Medicaid is income-based state-federal insurance
Medicare is a federal health insurance program primarily for people 65 and older or those with qualifying disabilities, while Medicaid is a joint state-federal program for individuals with low income.
Which FDA designation is granted to drugs targeting serious conditions where the drug demonstrates substantial improvement over available therapies?
Answer: Breakthrough Therapy Designation
Breakthrough Therapy Designation provides intensive FDA guidance and may expedite development for drugs showing early clinical evidence of substantial improvement.
What is the primary purpose of the FDA in pharmaceutical sales?
Answer: To regulate and approve drugs for safety and efficacy
The Food and Drug Administration (FDA) is a federal agency responsible for protecting public health by ensuring the safety, efficacy, and security of human and veterinary drugs, biological products, and medical devices. It rigorously reviews new drug applications before they can be marketed, ensuring they meet strict standards.
What is the PRIMARY ethical obligation of a certified Certified National Pharmaceutical Representative professional regarding confidential information?
Answer: Protect it from unauthorized disclosure at all times
Confidentiality is a fundamental ethical obligation. Certified professionals must protect confidential information from unauthorized disclosure, regardless of circumstances. Breach of confidentiality can result in loss of certification and legal liability.